Loading...
•
Sep 30, 2020
Acadia Healthcare Q3 2020 Earnings Report
Acadia Healthcare's Q3 2020 results reflected strong demand and cost management.
Key Takeaways
Acadia Healthcare reported revenue of $833.3 million for Q3 2020, compared to $777.3 million for Q3 2019. Net income attributable to Acadia stockholders for Q3 2020 was $37.0 million, or $0.42 per diluted share, compared to $42.6 million, or $0.48 per diluted share, for the same period in 2019.
Revenue for the third quarter of 2020 was $833.3 million, compared to $777.3 million for the third quarter of 2019.
Net income attributable to Acadia stockholders for the third quarter of 2020 was $37.0 million, or $0.42 per diluted share, compared to net income of $42.6 million, or $0.48 per diluted share, for the same period in 2019.
U.S. same facility revenue increased 7.5% with a 4.2% increase in patient days and a 3.1% increase in revenue per patient day, compared to the third quarter last year.
Acadia added 100 beds to U.S. operations during the quarter, bringing the total to 206 new bed additions in 2020.
Forward Guidance
Acadia established its financial guidance for the fourth quarter of 2020: Revenue in a range of $810 million to $835 million; Adjusted EBITDA in a range of $160 million to $165 million; and Adjusted earnings per diluted share in a range of $0.68 to $0.72. The Company’s guidance does not include the impact of any future acquisitions or transaction-related expenses.
Positive Outlook
- Revenue in a range of $810 million to $835 million
- Adjusted EBITDA in a range of $160 million to $165 million
- Adjusted earnings per diluted share in a range of $0.68 to $0.72
- Guidance does not include the impact of any future acquisitions
- Guidance does not include the impact of any transaction-related expenses
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...